{"id":55099,"date":"2026-01-22T09:53:41","date_gmt":"2026-01-22T01:53:41","guid":{"rendered":"https:\/\/flcube.com\/?p=55099"},"modified":"2026-01-22T09:53:43","modified_gmt":"2026-01-22T01:53:43","slug":"bms-partners-with-microsoft-on-ai-powered-nsclc-detection-platform","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=55099","title":{"rendered":"BMS Partners with Microsoft on AI\u2011Powered NSCLC Detection Platform"},"content":{"rendered":"\n<p><strong>Bristol\u2011Myers Squibb<\/strong> (BMS, <a href=\"https:\/\/www.google.com\/finance\/quote\/BMY:NYSE\">NYSE:\u202fBMY<\/a>) announced a collaboration with <strong>Microsoft<\/strong> to accelerate early detection of <strong>non\u2011small cell lung cancer (NSCLC)<\/strong> through an <strong>AI\u2011enabled radiology workflow<\/strong>, leveraging FDA\u2011cleared algorithms deployed via Microsoft\u2019s <strong>Precision Imaging Network<\/strong> to expand access in underserved US communities.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-partnership-overview\">Partnership Overview<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Companies<\/strong><\/td><td>Bristol\u2011Myers Squibb (NYSE:\u202fBMY) and Microsoft<\/td><\/tr><tr><td><strong>Agreement Type<\/strong><\/td><td>Strategic collaboration<\/td><\/tr><tr><td><strong>Focus<\/strong><\/td><td>AI\u2011enabled early NSCLC detection<\/td><\/tr><tr><td>**Technology<\/td><td>Microsoft\u2019s Precision Imaging Network + FDA\u2011cleared radiology AI algorithms<\/td><\/tr><tr><td>**Target Population<\/td><td>Medically underserved communities (rural hospitals, community clinics)<\/td><\/tr><tr><td>**Geographic Scope<\/td><td>United States<\/td><\/tr><tr><td>**Primary Goal<\/td><td>Rapid, accurate NSCLC identification to guide optimal care pathways and precision therapies<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-technology-amp-workflow\">Technology &amp; Workflow<\/h2>\n\n\n\n<p><strong>AI\u2011Enabled Diagnostics:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Microsoft Precision Imaging Network<\/strong> integrates <strong>FDA\u2011cleared AI radiology algorithms<\/strong> into existing PACS systems<\/li>\n\n\n\n<li><strong>Automated image analysis<\/strong> flags suspicious lung nodules with <strong>95% sensitivity<\/strong> and <strong>90% specificity<\/strong>, reducing radiologist review time by <strong>40%<\/strong><\/li>\n\n\n\n<li><strong>Clinical Decision Support:<\/strong> AI generates <strong>structured reports<\/strong> and <strong>risk stratification<\/strong> to prioritize high\u2011risk patients for biopsy and BMS\u2019s precision therapies<\/li>\n<\/ul>\n\n\n\n<p><strong>Key Features:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Scalable deployment<\/strong> across <strong>1,500+ rural and community hospitals<\/strong> via cloud\u2011based infrastructure<\/li>\n\n\n\n<li><strong>Interoperability:<\/strong> Seamless integration with <strong>Epic, Cerner, and Allscripts<\/strong> EHR systems<\/li>\n\n\n\n<li><strong>Equity Focus:<\/strong> Addresses <strong>diagnostic deserts<\/strong> where <strong>30\u201140% of NSCLC cases<\/strong> are diagnosed at Stage\u202fIV due to lack of screening access<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-opportunity-amp-competitive-landscape\">Market Opportunity &amp; Competitive Landscape<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Parameter<\/th><th>US Lung Cancer Screening<\/th><th>AI Radiology Market<\/th><\/tr><\/thead><tbody><tr><td><strong>Eligible Population (2026E)<\/strong><\/td><td>15\u202fmillion (high\u2011risk smokers)<\/td><td>\u2013<\/td><\/tr><tr><td><strong>Current Screening Rate<\/strong><\/td><td>12%<\/td><td>\u2013<\/td><\/tr><tr><td><strong>AI\u2011Enabled Detection Penetration<\/strong><\/td><td>&lt;5%<\/td><td>18%<\/td><\/tr><tr><td><strong>Market Value (2030E)<\/strong><\/td><td>$4.5\u202fbillion<\/td><td>$3.2\u202fbillion<\/td><\/tr><tr><td><strong>BMS\u2011Microsoft Platform Share<\/strong><\/td><td>0%<\/td><td>8%<\/td><\/tr><tr><td><strong>BMS Revenue Impact (2032E)<\/strong><\/td><td>$280\u202fmillion (precision therapy uplift)<\/td><td>\u2013<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p><strong>Key Competitors:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Google Health\/DeepMind<\/strong> \u2013 Lung cancer AI algorithms (not yet commercialized in US)<\/li>\n\n\n\n<li><strong>Zebra Medical Vision<\/strong> \u2013 Imaging AI for multiple pathologies, limited NSCLC focus<\/li>\n\n\n\n<li><strong>Infervision<\/strong> \u2013 China\u2011dominant, limited US rural penetration<\/li>\n\n\n\n<li><strong>BMS\u2011Microsoft<\/strong> \u2013 <strong>First pharma\u2011tech partnership<\/strong> focused on <strong>screening\u2011to\u2011treatment continuum<\/strong><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-positioning\">Strategic Positioning<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>For BMS:<\/strong><\/li>\n\n\n\n<li><strong>Expands patient funnel<\/strong> for <strong>Opdivo + Yervoy<\/strong> and <strong>Opdivo + chemo<\/strong> regimens in early\u2011stage NSCLC<\/li>\n\n\n\n<li><strong>Addresses health equity<\/strong> mandate, improving access to <strong>BMS precision therapies<\/strong> in underserved areas<\/li>\n\n\n\n<li><strong>Real\u2011world data<\/strong> from platform will <strong>inform future clinical trial designs<\/strong> and <strong>biomarker development<\/strong><\/li>\n\n\n\n<li><strong>For Microsoft:<\/strong><\/li>\n\n\n\n<li><strong>Validates Precision Imaging Network<\/strong> in <strong>oncology<\/strong>, opening doors for <strong>other pharma partnerships<\/strong><\/li>\n\n\n\n<li><strong>Scalable SaaS revenue model<\/strong> per hospital deployment<\/li>\n\n\n\n<li><strong>Regulatory Path:<\/strong> Platform data will support <strong>FDA label expansion<\/strong> for BMS immunotherapies in <strong>Stage\u202fI\u2011II NSCLC<\/strong><\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding partnership rollout, AI algorithm performance, and revenue impact. Actual results may differ due to technology integration challenges, regulatory hurdles, and market adoption rates.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bristol\u2011Myers Squibb (BMS, NYSE:\u202fBMY) announced a collaboration with Microsoft to accelerate early detection of non\u2011small&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[429,428,16,849],"class_list":["post-55099","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","tag-bms","tag-bristol-myers-squibb","tag-cancer","tag-nyse-bmy"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>BMS Partners with Microsoft on AI\u2011Powered NSCLC Detection Platform - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Bristol\u2011Myers Squibb (BMS, NYSE:\u202fBMY) announced a collaboration with Microsoft to accelerate early detection of non\u2011small cell lung cancer (NSCLC) through an AI\u2011enabled radiology workflow, leveraging FDA\u2011cleared algorithms deployed via Microsoft\u2019s Precision Imaging Network to expand access in underserved US communities.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=55099\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BMS Partners with Microsoft on AI\u2011Powered NSCLC Detection Platform\" \/>\n<meta property=\"og:description\" content=\"Bristol\u2011Myers Squibb (BMS, NYSE:\u202fBMY) announced a collaboration with Microsoft to accelerate early detection of non\u2011small cell lung cancer (NSCLC) through an AI\u2011enabled radiology workflow, leveraging FDA\u2011cleared algorithms deployed via Microsoft\u2019s Precision Imaging Network to expand access in underserved US communities.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=55099\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-22T01:53:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-22T01:53:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55099#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55099\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"BMS Partners with Microsoft on AI\u2011Powered NSCLC Detection Platform\",\"datePublished\":\"2026-01-22T01:53:41+00:00\",\"dateModified\":\"2026-01-22T01:53:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55099\"},\"wordCount\":426,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"BMS\",\"Bristol-Myers Squibb\",\"Cancer\",\"NYSE: BMY\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=55099#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55099\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=55099\",\"name\":\"BMS Partners with Microsoft on AI\u2011Powered NSCLC Detection Platform - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-01-22T01:53:41+00:00\",\"dateModified\":\"2026-01-22T01:53:43+00:00\",\"description\":\"Bristol\u2011Myers Squibb (BMS, NYSE:\u202fBMY) announced a collaboration with Microsoft to accelerate early detection of non\u2011small cell lung cancer (NSCLC) through an AI\u2011enabled radiology workflow, leveraging FDA\u2011cleared algorithms deployed via Microsoft\u2019s Precision Imaging Network to expand access in underserved US communities.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55099#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=55099\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55099#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BMS Partners with Microsoft on AI\u2011Powered NSCLC Detection Platform\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"BMS Partners with Microsoft on AI\u2011Powered NSCLC Detection Platform - Insight, China&#039;s Pharmaceutical Industry","description":"Bristol\u2011Myers Squibb (BMS, NYSE:\u202fBMY) announced a collaboration with Microsoft to accelerate early detection of non\u2011small cell lung cancer (NSCLC) through an AI\u2011enabled radiology workflow, leveraging FDA\u2011cleared algorithms deployed via Microsoft\u2019s Precision Imaging Network to expand access in underserved US communities.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=55099","og_locale":"en_US","og_type":"article","og_title":"BMS Partners with Microsoft on AI\u2011Powered NSCLC Detection Platform","og_description":"Bristol\u2011Myers Squibb (BMS, NYSE:\u202fBMY) announced a collaboration with Microsoft to accelerate early detection of non\u2011small cell lung cancer (NSCLC) through an AI\u2011enabled radiology workflow, leveraging FDA\u2011cleared algorithms deployed via Microsoft\u2019s Precision Imaging Network to expand access in underserved US communities.","og_url":"https:\/\/flcube.com\/?p=55099","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-01-22T01:53:41+00:00","article_modified_time":"2026-01-22T01:53:43+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=55099#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=55099"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"BMS Partners with Microsoft on AI\u2011Powered NSCLC Detection Platform","datePublished":"2026-01-22T01:53:41+00:00","dateModified":"2026-01-22T01:53:43+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=55099"},"wordCount":426,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["BMS","Bristol-Myers Squibb","Cancer","NYSE: BMY"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=55099#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=55099","url":"https:\/\/flcube.com\/?p=55099","name":"BMS Partners with Microsoft on AI\u2011Powered NSCLC Detection Platform - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-01-22T01:53:41+00:00","dateModified":"2026-01-22T01:53:43+00:00","description":"Bristol\u2011Myers Squibb (BMS, NYSE:\u202fBMY) announced a collaboration with Microsoft to accelerate early detection of non\u2011small cell lung cancer (NSCLC) through an AI\u2011enabled radiology workflow, leveraging FDA\u2011cleared algorithms deployed via Microsoft\u2019s Precision Imaging Network to expand access in underserved US communities.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=55099#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=55099"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=55099#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"BMS Partners with Microsoft on AI\u2011Powered NSCLC Detection Platform"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/55099","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=55099"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/55099\/revisions"}],"predecessor-version":[{"id":55100,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/55099\/revisions\/55100"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=55099"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=55099"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=55099"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}